1. Home
  2. ELSE vs MDCX Comparison

ELSE vs MDCX Comparison

Compare ELSE & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Electro-Sensors Inc.

ELSE

Electro-Sensors Inc.

N/A

Current Price

$7.71

Market Cap

27.1M

Sector

Industrials

ML Signal

N/A

Logo Medicus Pharma Ltd.

MDCX

Medicus Pharma Ltd.

HOLD

Current Price

$0.39

Market Cap

23.6M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELSE
MDCX
Founded
1968
2008
Country
United States
United States
Employees
N/A
16
Industry
Industrial Machinery/Components
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
27.1M
23.6M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
ELSE
MDCX
Price
$7.71
$0.39
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$14.50
AVG Volume (30 Days)
5.8K
1.7M
Earning Date
05-08-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$10,142,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
8.20
N/A
52 Week Low
$4.10
$0.25
52 Week High
$7.75
$3.35

Technical Indicators

Market Signals
Indicator
ELSE
MDCX
Relative Strength Index (RSI) 67.54 49.94
Support Level $7.63 $0.38
Resistance Level $7.75 $0.50
Average True Range (ATR) 0.02 0.04
MACD -0.01 -0.01
Stochastic Oscillator 92.31 38.17

Price Performance

Historical Comparison
ELSE
MDCX

About ELSE Electro-Sensors Inc.

Electro-Sensors Inc manufactures and sells industrial production monitoring and process control systems. It manufactures a complete line of monitoring and control systems for a wide range of industrial machine applications. The systems measure machine production and operation rates, as well as regulate the speed of related machines in production processes. Its products include motor drive control, position monitors, sensor targets, signal conditioners, speed sensors, speed switches, tachometers, temperature sensors, vibration monitors, etc.

About MDCX Medicus Pharma Ltd.

Medicus Pharma Ltd is a clinical-stage, life sciences, biotech company focused on investing in and accelerating clinical development programs of novel and potentially disruptive therapeutic assets. The company has one operating segment.

Share on Social Networks: